2024
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) ∗
Miller J, Binnicker M, Campbell S, Carroll K, Chapin K, Gonzalez M, Harrington A, Jerris R, Kehl S, Leal S, Patel R, Pritt B, Richter S, Robinson-Dunn B, Snyder J, Telford S, Theel E, Thomson R, Weinstein M, Yao J. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) ∗. Clinical Infectious Diseases 2024, ciae104. PMID: 38442248, DOI: 10.1093/cid/ciae104.Peer-Reviewed Original ResearchInfectious Diseases Society of AmericaSoft tissue infectionsTissue infectionsTract infectionsMicrobiology laboratoryCentral nervous system infectionLower respiratory tract infectionsUrinary tract infectionHead and neckInfectious Diseases SocietyNervous system infectionRespiratory tract infectionsTissue parasite infectionsUpper respiratory infectionAmerican Society for MicrobiologyProlonged turnaround timeInfectious diseasesTests to orderGenital infectionIntraabdominal infectionsBloodstream infectionsOcular infectionsDiagnosis of infectious diseasesViral syndromeJoint infection
2021
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus–Seronegative Recipients of the HSV529 Vaccine
Wang K, Dropulic L, Bozekowski J, Pietz H, Jegaskanda S, Dowdell K, Vogel J, Garabedian D, Oestreich M, Nguyen H, Ali M, Lumbard K, Hunsberger S, Reifert J, Haynes W, Sawyer J, Shon J, Daugherty P, Cohen J. Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus–Seronegative Recipients of the HSV529 Vaccine. The Journal Of Infectious Diseases 2021, 224: 1509-1519. PMID: 33718970, PMCID: PMC8599754, DOI: 10.1093/infdis/jiab139.Peer-Reviewed Original ResearchConceptsVaccine recipientsHSV-2Genital tractNatural killer (NK) cell activityCell activationHerpes simplex virus type 2Replication-defective vaccinesNK cell activitySerum neutralizing antibody responsesNeutralizing antibody responsesAntibodies to epitopesCervicovaginal fluidGenital infectionGenital herpesAntibody profilesNeutralization titersHSV529Antibody responseSerum antibodiesHerpesType 2GD antibodiesAntibodiesSerumVaccine
2020
Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine
Yu H, Karunakaran KP, Jiang X, Chan Q, Rose C, Foster LJ, Johnson RM, Brunham RC. Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine. Vaccine 2020, 38: 3280-3291. PMID: 32151463, DOI: 10.1016/j.vaccine.2020.02.059.Peer-Reviewed Original ResearchConceptsChlamydial outer membrane complexRecombinant outer membrane proteinsImmune responseT-cell vaccine candidatesElementary bodiesReactive immune responsesC. muridarum elementary bodiesGenital infectionMajor Outer Membrane ProteinTubal pathologyC. trachomatis serovarsVaccine efficacyOuter membrane proteinsSuperior efficacyVaccine candidatesBroad immunogenicityC. trachomatisVaccineAntibodiesSuperior protectionMultiple outer membrane proteinsOuter membrane complexPathologyEfficacyPolymorphic membrane proteins
2018
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S, Theel ES, Thomson RB, Weinstein MP, Yao JD. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya. Clinical Infectious Diseases 2018, 67: 813-816. PMID: 30169655, DOI: 10.1093/cid/ciy584.Peer-Reviewed Original ResearchSoft tissue infectionsSystem infectionTissue infectionsCentral nervous system infectionInfectious diseasesIntra-abdominal infectionsLower respiratory infectionsNervous system infectionInfectious Diseases SocietyMicrobiology laboratoryUrinary tract infectionAdvanced practice providersViral syndromeGenital infectionTract infectionsDiseases SocietyRespiratory infectionsJoint infectionOcular infectionsPediatric needsPractice providersGastrointestinal tractInfectious disease diagnosisHealthcare teamInfectionA Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S, Theel ES, Thomson RB, Weinstein MP, Yao JD. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya. Clinical Infectious Diseases 2018, 67: e1-e94. PMID: 29955859, PMCID: PMC7108105, DOI: 10.1093/cid/ciy381.Peer-Reviewed Original ResearchConceptsSoft tissue infectionsSystem infectionTissue infectionsCentral nervous system infectionInfectious diseasesIntra-abdominal infectionsLower respiratory infectionsNervous system infectionInfectious Diseases SocietyMicrobiology laboratoryUrinary tract infectionAdvanced practice providersViral syndromeGenital infectionTract infectionsDiseases SocietyRespiratory infectionsJoint infectionOcular infectionsPediatric needsPractice providersGastrointestinal tractInfectious disease diagnosisHealthcare teamInfection
2013
Potential Cost-Effectiveness of Schistosomiasis Treatment for Reducing HIV Transmission in Africa – The Case of Zimbabwean Women
Mbah M, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. Potential Cost-Effectiveness of Schistosomiasis Treatment for Reducing HIV Transmission in Africa – The Case of Zimbabwean Women. PLOS Neglected Tropical Diseases 2013, 7: e2346. PMID: 23936578, PMCID: PMC3731236, DOI: 10.1371/journal.pntd.0002346.Peer-Reviewed Original ResearchConceptsFemale genital schistosomiasisHIV infectionPraziquantel administrationHIV transmissionSchool-aged childrenAnnual administrationHIV prevalenceSchistosoma haematobiumCost-effective public health interventionsAntenatal clinic dataReducing HIV TransmissionBurden of HIVCases of HIVTen-year periodPublic health interventionsCost-effectiveness analysisNovel intervention strategiesGenital schistosomiasisGenital infectionSaharan AfricaCost-saving strategyNet savingsSchistosomiasis treatmentEpidemiological dataClinic dataCost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa
Mbah M, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 7952-7957. PMID: 23589884, PMCID: PMC3651507, DOI: 10.1073/pnas.1221396110.Peer-Reviewed Original ResearchConceptsCommunity-based interventionsHIV infectionHIV transmissionSchistosoma haematobiumFemale genital schistosomiasisAdministration of praziquantelSaharan AfricaRural ZimbabweS. haematobium transmissionGenital schistosomiasisGenital infectionHealth payersSchool-aged childrenIntervention periodEpidemiological dataEpidemiological studiesS. haematobiumSchistosomiasis prevalenceHealth educationInfectionSchistosomiasisYoung womenHaematobiumInterventionHIV
2003
The role of dendritic cells in immune responses against vaginal infection by herpes simplex virus type 2
Iwasaki A. The role of dendritic cells in immune responses against vaginal infection by herpes simplex virus type 2. Microbes And Infection 2003, 5: 1221-1230. PMID: 14623018, DOI: 10.1016/j.micinf.2003.09.006.Peer-Reviewed Original ResearchConceptsHerpes simplex virus type 2Simplex virus type 2Virus type 2Dendritic cellsType 2Female genital mucosaSpecialized dendritic cellsEffector immunityGenital ulcersGenital herpesGenital infectionGenital mucosaProtective immunityLeading causeVaginal infectionsImmune responseAdaptive immunityMore womenImmunityRecent evidenceInfectionSpecific subsetCellsUlcersHerpes
2001
Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women
Fawzi W, Msamanga G, Renjifo B, Spiegelman D, Urassa E, Hashemi L, Antelman G, Essex M, Hunter D. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS 2001, 15: 1157-1165. PMID: 11416718, DOI: 10.1097/00002030-200106150-00011.Peer-Reviewed Original ResearchConceptsViral loadHIV-1HIV-1-infected pregnant womenLower genital tract infectionMaternal CD4 cell countVertical transmissionLower genital infectionsMaternal viral loadCD4 cell countGenital tract infectionHIV disease progressionHIV-1 infectionWeeks of gestationPrevention of transmissionIntrapartum transmissionIntrauterine transmissionGenital infectionTract infectionsSustained clearanceClinical stagePregnant womenPrenatal careDisease progressionCopies/Vitamin supplements
1992
Recurrent Genital Infection in the Guinea Pig: Differences between Herpes Simplex Types 1 and 2
Landry M, Myerson D, Bull C. Recurrent Genital Infection in the Guinea Pig: Differences between Herpes Simplex Types 1 and 2. Intervirology 1992, 34: 169-179. PMID: 1339184, DOI: 10.1159/000150279.Peer-Reviewed Original ResearchConceptsHSV-2 strainsHSV-2HSV-1Genital infectionRecurrence rateHSV-1 McKrae strainType 1Herpes simplex virus type 2Simplex virus type 2Recurrent genital infectionsHerpes simplex type 1Guinea pig modelHSV type 1Simplex type 1HSV-1 strainsVirus type 2Vaginal virusAcute infectionLesion recurrenceOcular infectionsMcKrae strainGenital tractNervous systemType 2Guinea pigs
1988
Ability of Herpes Simplex Virus (HSV) Types 1 and 2 To Induce Clinical Disease and Establish Latency Following Previous Genital Infection with the Heterologous HSV Type
Landry M, Zibello T. Ability of Herpes Simplex Virus (HSV) Types 1 and 2 To Induce Clinical Disease and Establish Latency Following Previous Genital Infection with the Heterologous HSV Type. The Journal Of Infectious Diseases 1988, 158: 1220-1226. PMID: 2848899, DOI: 10.1093/infdis/158.6.1220.Peer-Reviewed Original ResearchConceptsHerpes simplex virus type 1Simplex virus type 1Virus type 1Clinical diseaseHSV typesSuperinfecting virusType 1Heterologous virus typesPrevious genital infectionsLevels of serumHSV antibodiesGenital infectionHSV-2Prior infectionLatent infectionHSV-1Type 2Months postinoculationGuinea pigsVirus typeInitial virusLatent virusSuperinfectionInfectionDisease
1982
Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig
Landry M, Lucia H, Hsiung GD, Pronovost A, Dann P, August M, Mayo D. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig. The American Journal Of Medicine 1982, 73: 143-150. PMID: 6285705, DOI: 10.1016/0002-9343(82)90080-8.Peer-Reviewed Original ResearchConceptsHSV-2 infectionHerpes simplex virus type 1Simplex virus type 1Genital infectionVirus type 1Lumbosacral gangliaHSV-2Clinical diseaseLatent infectionHSV-1Guinea pigsHSV-1-infected animalsHSV-2-infected animalsType 1Herpes simplex virus type 2Simplex virus type 2Acyclovir-treated groupEffect of acyclovirHSV-1 strainsVirus type 2Systemic treatmentAcute infectionMild diseaseSpinal cordChronic changes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply